Overview

AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation

Status:
Not yet recruiting
Trial end date:
2029-03-31
Target enrollment:
Participant gender:
Summary
A study comparing atrioventricular junction ablation (AVJA) versus continued optimum medical rate control in patients with cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) with suboptimal heart rate control on optimum medication.
Phase:
N/A
Details
Lead Sponsor:
University Hospital Ostrava